Thomas Atkinson, PhD

Memorial Sloan Kettering Cancer Center
New York, New York, United States

Presentation(s):

• Paper 81 - PSYCHOMETRIC PROPERTIES AND MEANINGFUL CHANGE THRESHOLDS (MCT) OF THE GOUNDER/DESMOID TUMOR RESEARCH FOUNDATION DESMOID SYMPTOM/IMPACT SCALE (GODDESS) AS ASSESSED IN THE PHASE 3 DEFI TRIAL

  Saturday, November 19, 2022
  1:30 PM – 1:42 PM